User profiles for Evangelia Yannaki

Evangelia Yannaki

UNIVERSITY OF WASHINGTON, GEORGE PAPANIKOLAOU HOSPITAL
Verified email at uw.edu
Cited by 3782

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non …

…, A Ganser, M Stadler, E Yannaki… - The lancet …, 2009 - thelancet.com
Background Procedures to prevent severe graft-versus-host disease (GVHD) delay immune
reconstitution secondary to transplants of haploidentical haemopoietic stem cells for the …

[HTML][HTML] G-CSF–primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous …

E Yannaki, E Athanasiou, A Xagorari… - Experimental …, 2005 - Elsevier
OBJECTIVE: On the basis of the recently recognized potential of bone marrow (BM) cells to
give rise to hepatocytes, we investigated the possibility that granulocyte colony-stimulating …

A chromatin insulator protects retrovirus vectors from chromosomal position effects

DW Emery, E Yannaki, J Tubb… - Proceedings of the …, 2000 - National Acad Sciences
Recombinant murine retroviruses are widely used as delivery vectors for gene therapy.
However, once integrated into a chromosome, these vectors often suffer from profound position …

SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial

…, A Fylaktou, S Tryfon, A Anagnostopoulos, E Yannaki - Nature Medicine, 2023 - nature.com
Despite advances, few therapeutics have shown efficacy in severe coronavirus disease 2019
(COVID-19). In a different context, virus-specific T cells have proven safe and effective. We …

In vivo HSC prime editing rescues sickle cell disease in a mouse model

…, H Wang, HP Kiem, DR Liu, E Yannaki… - Blood, The Journal …, 2023 - ashpublications.org
Sickle cell disease (SCD) is a monogenic disease caused by a nucleotide mutation in the β-globin
gene. Current gene therapy studies are mainly focused on lentiviral vector–mediated …

Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis

…, A Fassas, A Anagnostopoulos, E Yannaki - Annals of the …, 2012 - ard.bmj.com
Objective The role of mesenchymal stem cells (MSC) in experimental arthritis is undoubtedly
conflicting. This study explored the effect of bone marrow-derived MSC in previously …

Disruption of the BCL11A erythroid enhancer reactivates fetal hemoglobin in erythroid cells of patients with β-thalassemia major

…, A Reik, S Phelps, Y Zhou, D Dalas, E Yannaki… - … Therapy-Methods & …, 2018 - cell.com
In the present report, we carried out clinical-scale editing in adult mobilized CD34+ hematopoietic
stem and progenitor cells (HSPCs) using zinc-finger nuclease-mediated disruption of …

Maritime route of colonization of Europe

P Paschou, P Drineas, E Yannaki… - Proceedings of the …, 2014 - National Acad Sciences
The Neolithic populations, which colonized Europe approximately 9,000 y ago, presumably
migrated from Near East to Anatolia and from there to Central Europe through Thrace and …

[HTML][HTML] Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells

E Yannaki, A Anagnostopoulos, D Kapetanos… - Experimental …, 2006 - Elsevier
For end-stage liver disease, liver transplantation provides the only definite cure; however,
many patients die while in the waiting list for donation. Various stem cell populations have …

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice

…, A Mishra, S Gil, RD Hawkins, E Yannaki… - Blood …, 2021 - ashpublications.org
Base editors are capable of installing precise genomic alterations without creating double-strand
DNA breaks. In this study, we targeted critical motifs regulating γ-globin reactivation …